Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults

American Journal of Rhinology and Allergy

Volumn 25, Issue 6, 2011, Pages

  Zeng, Ming ^a   Long, Xiao Bo ^a   Cui, Yong Hua ^a   Liu, Zheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; MOMETASONE FUROATE;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPY; CHINESE; CIGARETTE SMOKING; CLINICAL ARTICLE; COMORBIDITY; DRUG EFFICACY; ENDOSCOPY; FEMALE; HEADACHE; HUMAN; MALE; NOSE OBSTRUCTION; NOSE POLYP; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; RHINOSINUSITIS; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHINA; CHRONIC DISEASE; CLARITHROMYCIN; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; PREGNADIENEDIOLS; PROSPECTIVE STUDIES; RHINITIS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SINUSITIS; TREATMENT OUTCOME;

EID: 84455182314     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2011.25.3728     Document Type: Article

References (26)

1. Fokkens W, Lund V, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 20:1-136, 2007.
2. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: Establishing definitions for clinical research and patient care. J Allergy Clin Immunol 114:155-212, 2004. (Pubitemid 39575875)
3. Piromchai P, Thanaviratananich S, and Laopaiboon M. Systemic antibiotics for chronic rhinosinusitis without nasal polyps in adults. Cochrane Database Syst Rev 5:CD008233, 2011.
4. Tauber SC, and Nau R. Immunomodulatory properties of antibiotics. Curr Mol Pharmacol 1:68-79, 2008.
5. Suzuki H, Ikeda K, Honma R, et al. Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy. ORL J Otorhinolaryngol Relat Spec 62:121-127, 2000. (Pubitemid 30248562)
6. Harvey RJ, Wallwork BD, and Lund VJ. Anti-inflammatory effects of macrolides: Applications in chronic rhinosinusitis. Immunol Allergy Clin North Am 29:689-703, 2009.
7. Baschant U, and Tuckermann J. The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol 120:69-75, 2010.
8. Zen M, Canova M, Campana C, et al. The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev 10:305-310, 2011.
9. Barnes PJ. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms. Clin Sci (Lond) 94:557-572, 1998. (Pubitemid 28269054)
10. McColl A, Bournazos S, Franz S, et al. Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. J Immunol 183:2167-2175, 2009.
11. Joe SA, Thambi R, and Huang J. A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis. Otolaryngol Head Neck Surg 139:340-347, 2008.
12. Cao PP, Li HB, Wang BF, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol 124:478-484, 2009.
13. Wallwork B, Coman W, Feron F, et al. Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis. Laryngoscope 112:1827-1830, 2002.
14. Van Bruaene N, Pérez-Novo CA, Basinski TM, et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol 121:1435-1441, 2008.
15. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31:143-178, 2008.
16. Lanza DC, and Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 117:S1-S7, 1997. (Pubitemid 27435423)
17. Aukema AA, and Fokkens WJ. Chronic rhinosinusitis: Management for optimal outcomes. Treat Respir Med 3:97-105, 2004. (Pubitemid 38578922)
18. Wallwork B, Coman W, Mackay-Sim A, et al. A double-blind, randomized placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 116:189-193, 2006. (Pubitemid 44383921)
19. Holbrook EH, Brown CL, Lyden ER, et al. Lack of significant correlation between rhinosinusitis symptoms and specific regions of sinus computer tomography scans. Am J Rhinol 19:382-387, 2005. (Pubitemid 41341781)
20. Salapatek AM, Patel P, Gopalan G, et al. Mometasone furoate nasal spray provides early, continuing relief of nasal congestion and improves nasal patency in allergic patients. Am J Rhinol Allergy 24:433-438, 2010.
21. Anolik R, Pearlman D, Teper A, et al. Mometasone furoate improves nasal and ocular symptoms of seasonal allergic rhinitis in adolescents. Allergy Asthma Proc 30:406-412, 2009.
22. Wandalsen GF, Mendes AI, and Solé D. Objective improvement in nasal congestion and nasal hyperreactivity with use of nasal steroids in persistent allergic rhinitis. Am J Rhinol Allergy 24:e32-e36, 2010.
23. Steinke JW, and Borish L. The role of allergy in chronic rhinosinusitis. Immunol Allergy Clin North Am 24:45-57, 2004. (Pubitemid 38210302)
24. Lavigne F, Nguyen CT, Cameron L, et al. Prognosis and prediction of response to surgery in allergic patients with chronic sinusitis. J Allergy Clin Immunol 105:746-751, 2000. (Pubitemid 30226449)
25. Cervin A, Wallwork B, Mackay-Sim A, et al. Effects of long-term clarithromycin treatment on lavage-fluid markers of inflammation in chronic rhinosinusitis. Clin Physiol Funct Imaging 29:136-142, 2009.
26. Stjarne P, Blomgren K, Caye-Thomasen P, et al. The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: A randomized, double-blind, placebo-controlled study. Acta Otolaryngol 126:606-612, 2006. (Pubitemid 43995212)